Glucose targets for preventing diabetic kidney disease and its progression

BACKGROUND: Diabetes is the leading cause of end‐stage kidney disease (ESKD) around the world. Blood pressure lowering and glucose control are used to reduce diabetes‐associated disability including kidney failure. However there is a lack of an overall evidence summary of the optimal target range fo...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Cochrane Database Syst Rev
Asıl Yazarlar: Ruospo, Marinella, Saglimbene, Valeria M, Palmer, Suetonia C, De Cosmo, Salvatore, Pacilli, Antonio, Lamacchia, Olga, Cignarelli, Mauro, Fioretto, Paola, Vecchio, Mariacristina, Craig, Jonathan C, Strippoli, Giovanni FM
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: John Wiley & Sons, Ltd 2017
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC6481869/
https://ncbi.nlm.nih.gov/pubmed/28594069
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/14651858.CD010137.pub2
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller